Diagnostics Q3 Revenue USD 100 Thousand
13/11/2025 21:01
Nov 13 (Reuters) - Co-Diagnostics Q3 net income USD -5.9 million. Q3 operating income USD -7 million Q3 operating expenses USD 7.1 million Q3 adjusted EBITDA USD -6.3 million Q3 EPS USD -0.16
Recent news on Co-Diagnostics
See all newsDiagnostics' Joint Venture Cosara Diagnostics Announces Publication Of Peer-Reviewed Hpv Screening Study Using Cosara's Saragene® Test
Diagnostics - Cosara To Initiate Sales Activities Across India And South Asia
Diagnostics’ Brian Brown Stepped Down As CFO Effective September 2
Diagnostics Q2 revenue rises slightly amid international expansion
Diagnostics - Amends Equity Distribution Agreement With Maxim Group For Common Stock Sale - SEC Filing